Spinal cord atrophy in triple A syndrome associated with a novel compound 
heterozygous mutation.

Kunte, H.; Trendelenburg, G.; Matzen, J.; Ventz, M.; Kornak, U.; Harms, L.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Spinal cord atrophy in triple A syndrome associated with a novel compound heterozygous mutation.

MPS-Authors

/persons/resource/persons50391

Kornak, U.
Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Kunte, H., Trendelenburg, G., Matzen, J., Ventz, M., Kornak, U., & Harms, L. (2010). Spinal cord atrophy in triple A syndrome associated with a novel compound heterozygous mutation. Neuro Endocrinology Letters, 31(3), 301-303. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20588230.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-7BB7-B

Abstract

A 38-year-old male patient was admitted with slowly progressive spastic gait disturbance. Imaging revealed general spinal cord atrophy. Because of adrenal insufficiency, alacrima and achalasia, triple A syndrome was suspected. This is a case report of a triple A syndrome patient with a predominance of neurological features and a new heterozygous compound mutation in triple A syndrome gene.